“The compound SR-17018 is the first biased agonist of the mu opioid receptor that does not bring on tolerance with Long-term use,” suggests Stahl, a senior team scientist within the Bohn lab. “That is a attractive aspect for possible use within the context of Long-term, severe agony.” Her work has not simply broadened knowledge of ho